Exploration of Angiogenesis in Decompensated Developmental Venous Abnormalities

Not Applicable

Terminated

• Conditions: Developmental Venous Anomaly

• Registration Number: NCT03986853
• Lead Sponsor: Hopital Foch

Brief Summary

The purpose of our study is to demonstrate by blood samples in situ in the vascular lesion (performed during any cerebral catheterization for an embolization of arteriovenous malformation) the existence of angiogenic growth factors and inflammatory factors that would confirm the decompensation of venous ischemia.

Detailed Description

Not available

Study Timeline

• Study Start: 2018-01-11
• Study First Submitted: 2019-06-13
• Study First Submitted QC: 2019-06-13
• Study First Posted: 2019-06-14
• Primary Completion: 2021-01-11
• Study Completion: 2021-01-11
• Status Verified: 2022-08
• Last Update Submitted: 2022-08-02
• Last Update Posted: 2022-08-04

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 3

Inclusion Criteria

• Presenting a DVA requiring hyperselective catheterization
• Having sign an informed consent form

Exclusion Criteria

• Presenting a contraindication to the realization of hyperselective cathterism

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Assessment of angiogenic and inflammatory growth factors	1 day	The 5th factor studied is angiopoietin-like 4

Trial Locations

Locations (1)

Hôpital Foch; 🇫🇷 Suresnes, France